Keurig Dr Pepper Inc. quarterly report, Q3 FY2014

Vollständiges Dokument

Business context and reporting period

The supplied filing is Dr Pepper Snapple Group, Inc.’s unaudited Form 10-Q for the quarter ended September 30, 2014, with comparisons to the three and nine months ended September 30, 2013. The issuer does not match the request metadata naming Keurig Dr Pepper Inc.; verify the intended company and filing before relying on this summary. Dr Pepper Snapple operated Beverage Concentrates, Packaged Beverages, and Latin America Beverages segments.

Key financial metrics

Amounts are in U.S. dollars; financial statement figures are in millions except per-share data.

  • Quarter: Net sales were $1.583 billion, up 3%; gross profit was $925 million and gross margin was 58.4%, versus 57.9%. Operating income was $316 million, up 5%, with a 19.9% operating margin versus 19.4%. Net income was $188 million, down 9%; diluted EPS was $0.96 versus $1.01.
  • First nine months: Net sales were $4.612 billion, up 2%; gross profit was $2.735 billion and gross margin was 59.3%, versus 57.7%. Operating income was $924 million, up 18%. Net income was $553 million, up 18%; diluted EPS was $2.79 versus $2.28.
  • Cash flow: Nine-month operating cash flow was $769 million, compared with $616 million. Investing cash outflow was $100 million, including $103 million of capital expenditures; financing cash outflow was $553 million. Cash increased to $266 million from $153 million at year-end 2013.
  • Liquidity and debt: Current assets were $1.241 billion and current liabilities $1.024 billion. Long-term obligations were $2.539 billion, including $2.482 billion of senior unsecured notes; short-term borrowings and current maturities were $2 million. No commercial paper was outstanding, and $499 million was available under the $500 million revolver. The company reported compliance with debt covenants.
  • Capital returns: Nine-month dividends paid were $237 million; the declared dividend was $0.41 per share for the quarter. The company repurchased $276 million of shares during the first nine months, with $296 million remaining under its authorization.

Material changes versus prior comparable periods

  • Quarterly revenue and operating income improved, but reported net income and diluted EPS declined. The comparison is distorted by 2013 tax-related items: an IRS audit conclusion produced a $463 million income tax benefit and a $430 million indemnity expense, while the filing says the tax benefit increased 2013 quarterly diluted EPS by $0.16.
  • For the nine-month comparison, 2013 also included those IRS-related items and a Canadian tax-law change. Excluding the specified prior-year tax and indemnity items, the filing presents a 2013 effective tax rate of 36.0%, versus 34.5% in 2014; reported rates were (53.1)% and 34.5%, respectively.
  • Quarterly volume (bottler case sales) rose 1% overall, with U.S. and Canada flat and Mexico and the Caribbean up 10%. Nine-month volume was flat overall: U.S. and Canada declined 1%, while Mexico and the Caribbean grew 7%.
  • For the first nine months, segment operating profit increased in all segments: Beverage Concentrates to $588 million from $560 million; Packaged Beverages to $478 million from $418 million; and Latin America Beverages to $59 million from $45 million. Latin America revenue growth benefited from volume and pricing, including the Mexican sugar tax.
  • Gross-margin improvement reflected lower commodity costs and productivity gains; the company cited higher logistics costs, promotional activity, foreign-exchange headwinds, and an unfavorable LIFO comparison as offsets or pressures.

Outlook, commentary, risks and unusual items

  • Management expected 2014 capital expenditures, net of disposals, to be approximately 3% of net sales. It stated operating cash flows should cover anticipated obligations for the next 12 months. No earnings or revenue guidance was provided in the supplied filing text.
  • Management cited beverage-market seasonality, economic and credit-market conditions, operating cash-flow seasonality, continued investment needs, dividends, share repurchases, and potential acquisitions as factors relevant to liquidity.
  • Key exposures include commodity prices, foreign exchange (particularly the Canadian dollar and Mexican peso), and interest rates. The filing estimates a 10% exchange-rate change could affect annual operating income by approximately $23 million; a 10% change in unhedged commodity prices was estimated to affect remaining-2014 operating income by approximately $3 million.
  • The company noted the Mexican sugar tax affected pricing, costs, and certain product volumes. It also recorded a $5 million charge in the quarter for an adjustment to spare-parts inventory.
  • Legal matters were not expected by management to have a material adverse effect, but an unresolved New Jersey Superfund-site investigation had no reasonably estimable cleanup-cost amount; the company had paid approximately $650,000 through September 30, 2014. The filing reported no material changes to previously disclosed risk factors.
  • Disclosure controls were deemed effective, with no material change in internal control over financial reporting during the quarter.

Important facts for investors to verify

  1. Confirm whether the intended filing is Dr Pepper Snapple Group’s 2014 Q3 10-Q, rather than a filing for the company named in the request metadata.
  2. Review the effect of the unusual 2013 IRS audit, tax, and Mondelēz indemnity items when assessing earnings comparisons.
  3. Assess the sustainability of margin gains given commodity prices, promotional spending, logistics costs, LIFO accounting, and the Mexican sugar tax.
  4. Check subsequent cash flows, debt maturities, capital spending, dividends, and share repurchases against management’s liquidity expectations.
  5. Monitor volume trends by brand and geography, particularly declines in Dr Pepper diet products and sugar-tax-affected Mexican brands, alongside growth in Peñafiel and selected water and ginger-ale products.